Back to LYEL

Ikarian Capital, LLC → LYEL

Ikarian Capital, LLC LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
4
Latest value
$402K
Q3 2026
Peak value
$1.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$1.3M
Q1 2026$824K
Q2 2026$577K
Q3 2026$402K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$402K41.1K——
Q2 2026$577K41.1K——
Q1 2026$824K41.1K——
Q4 2025$1.3M41.1K——

Other funds holding LYEL

Other Ikarian Capital, LLC positions

KOD

KODIAK SCIENCES INC

$50.5M
KOD

KODIAK SCIENCES INC

$48.3M
AAVXF

ABIVAX SA

$43.4M
KOD

KODIAK SCIENCES INC

$41.3M
AAVXF

ABIVAX SA

$29.1M
AAVXF

ABIVAX SA

$28.4M
JAZZ

JAZZ PHARMACEUTICALS PLC

$27.3M
ALMS

ALUMIS INC

$26.7M